Literature DB >> 19207265

Satellite cell dysfunction contributes to the progressive muscle atrophy in myotonic dystrophy type 1.

L-E Thornell1, M Lindstöm, V Renault, A Klein, V Mouly, T Ansved, G Butler-Browne, D Furling.   

Abstract

AIMS: Myotonic dystrophy type 1 (DM1), one of the most common forms of inherited neuromuscular disorders in the adult, is characterized by progressive muscle weakness and wasting leading to distal muscle atrophy whereas proximal muscles of the same patients are spared during the early phase of the disease. In this report, the role of satellite cell dysfunction in the progressive muscular atrophy has been investigated.
METHODS: Biopsies were obtained from distal and proximal muscles of the same DM1 patients. Histological and immunohistological analyses were carried out and the past regenerative history of the muscle was evaluated. Satellite cell number was quantified in vivo and proliferative capacity was determined in vitro.
RESULTS: The size of the CTG expansion was positively correlated with the severity of the symptoms and the degree of muscle histopathology. Marked atrophy associated with typical DM1 features was observed in distal muscles of severely affected patients whereas proximal muscles were relatively spared. The number of satellite cells was significantly increased (twofold) in the distal muscles whereas very little regeneration was observed as confirmed by telomere analyses and developmental MyHC staining (0.3-3%). The satellite cells isolated from the DM1 distal muscles had a reduced proliferative capacity (36%) and stopped growing prematurely with telomeres longer than control cells (8.4 vs. 7.1 kb), indicating that the behaviour of these precursor cells was modified.
CONCLUSIONS: Our results indicate that alterations in the basic functions of the satellite cells progressively impair the muscle mass maintenance and/or regeneration resulting in gradual muscular atrophy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19207265     DOI: 10.1111/j.1365-2990.2009.01014.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  38 in total

1.  Strength training increases the size of the satellite cell pool in type I and II fibres of chronically painful trapezius muscle in females.

Authors:  Abigail L Mackey; Lars L Andersen; Ulrik Frandsen; Gisela Sjøgaard
Journal:  J Physiol       Date:  2011-09-26       Impact factor: 5.182

2.  Smad3 signaling is required for satellite cell function and myogenic differentiation of myoblasts.

Authors:  Xiaojia Ge; Craig McFarlane; Anuradha Vajjala; Sudarsanareddy Lokireddy; Zhi Hui Ng; Chek Kun Tan; Nguan Soon Tan; Walter Wahli; Mridula Sharma; Ravi Kambadur
Journal:  Cell Res       Date:  2011-04-19       Impact factor: 25.617

3.  Evaluating the effects of CELF1 deficiency in a mouse model of RNA toxicity.

Authors:  Yun Kyoung Kim; Mahua Mandal; Ramesh S Yadava; Luc Paillard; Mani S Mahadevan
Journal:  Hum Mol Genet       Date:  2013-09-02       Impact factor: 6.150

Review 4.  Modeling diseases of noncoding unstable repeat expansions using mutant pluripotent stem cells.

Authors:  Shira Yanovsky-Dagan; Hagar Mor-Shaked; Rachel Eiges
Journal:  World J Stem Cells       Date:  2015-06-26       Impact factor: 5.326

Review 5.  Molecular mechanisms of muscle atrophy in myotonic dystrophies.

Authors:  Lubov Timchenko
Journal:  Int J Biochem Cell Biol       Date:  2013-06-21       Impact factor: 5.085

Review 6.  Restoring the regenerative balance in neuromuscular disorders: satellite cell activation as therapeutic target in Pompe disease.

Authors:  Gerben J Schaaf; Rodrigo Canibano-Fraile; Tom J M van Gestel; Ans T van der Ploeg; W W M Pim Pijnappel
Journal:  Ann Transl Med       Date:  2019-07

7.  Alternative splicing dysregulation secondary to skeletal muscle regeneration.

Authors:  James P Orengo; Amanda J Ward; Thomas A Cooper
Journal:  Ann Neurol       Date:  2011-03-11       Impact factor: 10.422

8.  CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1.

Authors:  Amanda J Ward; Mendell Rimer; James M Killian; James J Dowling; Thomas A Cooper
Journal:  Hum Mol Genet       Date:  2010-07-05       Impact factor: 6.150

9.  NKX2-5, a modifier of skeletal muscle pathology due to RNA toxicity.

Authors:  Jordan T Gladman; Ramesh S Yadava; Mahua Mandal; Qing Yu; Yun K Kim; Mani S Mahadevan
Journal:  Hum Mol Genet       Date:  2014-08-28       Impact factor: 6.150

10.  Large-scale isolation of human skeletal muscle satellite cells from post-mortem tissue and development of quantitative assays to evaluate modulators of myogenesis.

Authors:  Ian C Scott; Wendy Tomlinson; Andrew Walding; Beverley Isherwood; Iain G Dougall
Journal:  J Cachexia Sarcopenia Muscle       Date:  2013-01-24       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.